All this talk about quarterly earnings and venture stats reminded me: I never posted my favorite stories from Xconomy Boston’s third quarter. Yes, I know it’s almost the end of October, and the third quarter ended a month ago. I must have been traumatized by the collapse of the Red Sox or something (is baseball … Continue reading “Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter”
Category: Boston
Vinod Khosla Helps Startup Entrepreneurs Think Bigger
I had been planning to talk in today’s column about the shortcomings of the Google Chromebook, which are numerous. But I’m in too good of a mood this week to play the critic, partly because of a terrific Silicon Valley event that I attended Tuesday night called Get Bigger! With Vinod Khosla. So instead, I’m … Continue reading “Vinod Khosla Helps Startup Entrepreneurs Think Bigger”
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News
It was a meaty New England life sciences week, with clinical advances, new funding, CEO hires, and acquisitions headlines. —Sanofi hired David Meeker as the new CEO of its Cambridge, MA-based Genzyme unit. Meeker, who got started at the company in 1994, will move into his new role on November 1 and will lead the … Continue reading “New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News”
Novomer Receives $10,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=702f9b73-aa87-4bcb-907c-e25ecdf92ac7&Preview=1 Date 10/28/2011 Company Name Novomer Mailing Address Reservoir Place 1601 Trapelo Rd. Waltham, MA 02451 Company Description Novomer is a new materials company pioneering a family of low-cost, high-performance, green plastics, polymers and other chemicals. A wide variety of packaging, commercial, consumer and industrial markets are looking for new, advanced materials … Continue reading “Novomer Receives $10,000,000 New Round”
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again
Vertex Pharmaceuticals has tallied up an amazing amount of red ink in its 22-year history, but now it can say that all those long R&D years have created a profitable business. The Cambridge, MA-based biotech company (NASDAQ: [[ticker:VRTX]]) said today that it generated $659 million in total revenues, and turned a profit of $221 million … Continue reading “Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again”
2011 Conference on Clean Energy
This day-long energy conference will feature a mix of presentations of established and startup cleantech companies, investors, and government players. Panels cover subjects from seed funding to state assistance to energy solutions in developing countries. Register here.
Network for Teaching Entrepreneurship Showcase
This is a meet and greet for those looking to find out who’s behind the Network for Teaching Entrepreneurship, which teaches a year-long course on entrepreneurship to low-income students. This night of networking should give attendees a better idea of what the group is doing in Boston. Sign up here.
Massachusetts Startup Investing Rose to $253.8M Last Month, Charged Up By Boston-Power’s $125M
There seems to be a theme in Massachusetts venture investing right now. Things aren’t quite as hot as they were earlier this year, but are still trumping last year’s numbers for the same period. That’s what my colleague Greg noted about the MoneyTree report for Q3 2011 venture investing. And that’s what I’ve observed here … Continue reading “Massachusetts Startup Investing Rose to $253.8M Last Month, Charged Up By Boston-Power’s $125M”
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs
South San Francisco-based Portola Pharmaceuticals has formed a lucrative alliance today with Biogen Idec (NASDAQ: [[ticker:BIIB]]) to co-develop drugs for autoimmune diseases, seeking to stop the immune system from attacking healthy tissues like a virus. Under the deal, Portola is granting Weston, MA-based Biogen Idec an exclusive worldwide license to co-develop oral pills that block … Continue reading “Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs”
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs
Two Boston-area startups—both of which emanated from the lab of MIT bioengineer and entrepreneur Bob Langer—announced today that they secured $25 million a piece in funding from Rusnano, a $10 billion Russian Federation fund that supports nanotechnology startups. The money went to Watertown, MA-based Selecta Biosciences and Cambridge, MA-based BIND Biosciences. Each company also added … Continue reading “BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs”
Xconomist of the Week: Phil Libin, Evernote, and the Death of the Exit
Xconomist Phil Libin, the CEO of Mountain View, CA-based Evernote, is a little unusual among his Silicon Valley brethren. He’s on the record as saying that the online notekeeping startup doesn’t want to be acquired. “There has never been an exit strategy at Evernote,” he wrote in an FAQ-style blog post after Evernote raised $50 … Continue reading “Xconomist of the Week: Phil Libin, Evernote, and the Death of the Exit”
Hipmunk, OnSwipe, MC10, Appature, Mimecast, and Northrop Grumman to Headline “6×6” Big Tech Ideas Conference Dec. 1
Daily deals and flash sales, please step off. Social-local-mobile recommendations, go fly a kite. Photo-sharing sites, go take a long walk off a short pier (and send me a picture). We don’t need more companies like those. Here’s what we need. Stretchy, bendy wearable computers. New tablet publishing models. High-altitude unmanned aerial vehicles (UAVs). The … Continue reading “Hipmunk, OnSwipe, MC10, Appature, Mimecast, and Northrop Grumman to Headline “6×6” Big Tech Ideas Conference Dec. 1″
Selecta Biosciences Garners $22,000,000 Series D Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e24ff8d-2064-49bc-8de1-445dfa22d209&Preview=1 Date 10/27/2011 Company Name Selecta Biosciences Mailing Address 480 Arsenal St. Building One Watertown, MA 02472 Company Description Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta’s proprietary Synthetic … Continue reading “Selecta Biosciences Garners $22,000,000 Series D Funding”
ConnectEDU Secures $10,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a9d3b65a-5d66-433a-88af-3afd0f8c4208&Preview=1 Date 10/27/2011 Company Name ConnectEDU Mailing Address 600 Atlantic Ave. 20th Floor Boston, MA 02210 Company Description ConnectEDU is the nation’s leading technology firm dedicated to providing students, educators and employers with comprehensive solutions to successfully navigate education and employment transitions. Website http://www.connectedu.net Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction … Continue reading “ConnectEDU Secures $10,000,000 New Financing Round”
Future Forward 2011
Information and registration details here. The 2011 edition of the Future Forward Executive Retreat will bring together a high-level group of entrepreneurs, CIOs, CTOs, CEOs, researchers, and investors. The program will be held at the Wellesley College Club. New to Future Forward, we’re encouraging all of our entrepreneur participants to bring a laptop demo (or … Continue reading “Future Forward 2011”
Atreaon and Arsenal Spinoff 480 Biomedical Nab Funds
Here are a couple of mid-week life sciences financings. —Watertown, MA-based Arsenal Medical, a developer of biomaterial-based scaffold and drug delivery products, announced it is spinning out a new company called 480 Biomedical. Both firms raised new funding ($15 million for 480 and $3 million for Arsenal) from Arsenal Medical’s return investors Polaris Venture Partners, … Continue reading “Atreaon and Arsenal Spinoff 480 Biomedical Nab Funds”
Biogen Idec’s Oral Multiple Sclerosis Drug Passes 2nd Major Test; Stock Soars
Biogen Idec’s new oral pill for multiple sclerosis passed its first pivotal trial back in April, and today the company got the confirmation it was looking for from a second major study. The Weston, MA-based biotech company (NASDAQ: [[ticker:BIIB]]) said today that dimethyl fumarate (BG-12) met its main goal of reducing multiple sclerosis flare-ups over … Continue reading “Biogen Idec’s Oral Multiple Sclerosis Drug Passes 2nd Major Test; Stock Soars”
IBM Names Virginia Rometty CEO and President
On Tuesday, IBM (NYSE: [[ticker:IBM]]) in Armonk, NY, said in a press statement there would be a changing of the guard at the onset of 2012. The company’s board elected Virginia Rometty to serve as CEO and president—as well as take a seat on the board—effective January 1. She succeeds Samuel J. Palmisano, who will … Continue reading “IBM Names Virginia Rometty CEO and President”
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme
The best thing about coming to the BIO Investor Forum in San Francisco every year is the schmoozing with folks from all over the country in one place. The worst thing? There’s not much in the way of breaking news. Oh well, sometimes you gotta do the spade work on a slow news day if … Continue reading “BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme”
Hadapt Gets Series A, Cisco Buys BNI, Cubist Acquisition of Adolor Valued at $415M, & More Boston-Area Deals News
Financing rounds, acquisitions, and business plan prizes have made up the New England deals news this week. —Continuing the West-Coast-company-buys-East-Coast-company trend of last week, San Jose, CA-based Cisco Systems announced its purchase of Boxborough, MA-based BNI Video, a developer of software for managing cable content on the back end and improving the browsing experience for … Continue reading “Hadapt Gets Series A, Cisco Buys BNI, Cubist Acquisition of Adolor Valued at $415M, & More Boston-Area Deals News”
Cubist Says Adolor Deal Offers “Free Option on Billion-Dollar Program”
Lexington, MA-based Cubist Pharmaceuticals (NASDAQ: [[ticker:CBST]]) had its eye on Adolor (NASDAQ: [[ticker:ADLR]]) long before it announced it would acquire the Exton, PA-based company on Monday. But it wasn’t until drug giant GlaxoSmithKline (NYSE: [[ticker:GSK]]) pulled out of a co-promotion deal with Adolor in June that Cubist could finally pounce. Glaxo and Adolor were partnered on a … Continue reading “Cubist Says Adolor Deal Offers “Free Option on Billion-Dollar Program””
CashStar Lands $12,000,000 Series C Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=619ae321-9d68-4ad3-8c5f-15018189bb8a&Preview=1 Date 10/26/2011 Company Name CashStar Mailing Address 129 Middle Street 2nd Floor Portland, ME 04101 Company Description CashStar is leading the multi-channel payments evolution as the only digital gifting and incentives company for top brands. The company works with national retailers to offer highly-personalized eGift Cards delivered to consumers via email. … Continue reading “CashStar Lands $12,000,000 Series C Financing”
iDevices Garners $150,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2e4914dc-53c3-4b76-b99a-128e5aeeab4e&Preview=1 Date 10/26/2011 Company Name iDevices Mailing Address 191 Albany Turnpike Canton, CT 06019 Company Description iDevices, LLC., is an American based company that creates and specializes in unique products using our extensive knowledge of wireless connectivity. In 2010 iDevices successfully developed and launched the iGrill, and the iGrill applications. The company … Continue reading “iDevices Garners $150,000 Seed Round”
Atreaon Obtains $8,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cc7965b-f2e0-4319-80e1-b441d694bc6d&Preview=1 Date 10/26/2011 Company Name Atreaon Mailing Address 1188 Centre St Newton Centre, MA 02459 Company Description The company has developed a synthetic version of the protein, called Atsttrin, and founded Atreaon to commercialize it as a treatment for arthritis. Website Undisclosed Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction Round Undisclosed … Continue reading “Atreaon Obtains $8,000,000 New Financing”
Finalta Garners $1,050,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a78f834c-4159-4815-a16c-d9326d9154f8&Preview=1 Date 10/26/2011 Company Name Finalta Mailing Address 1 Curve Street Bedford, MA 01730 Company Description Finalta provides elegant software solutions to the world’s institutional asset managers. Website Undisclosed Transaction Type Venture Equity Transaction Amount $1,050,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms Venture … Continue reading “Finalta Garners $1,050,000 New Funding”
iRobot Lays Off About 55 Staff in Advance of Q3 Earnings Report
[Updated 4:35 pm] Bedford, MA-based iRobot laid off about 55 people last week from its government and industrial robots division, Xconomy has learned. I heard from a source familiar with the company that some of the layoffs came to light because ex-employees posted on social media looking for new positions. An iRobot spokesperson did not … Continue reading “iRobot Lays Off About 55 Staff in Advance of Q3 Earnings Report”
Life Is Good, Listen to People, and More Takeaways from Bert Jacobs at MassChallenge
Life is not good when you lose your notes from one of the best keynotes you’ve seen in a while. In fact, life kind of sucks. Nevertheless, I will recount my top five takeaways from Bert Jacobs, the co-founder and CEO of Life Is Good, the Boston-based apparel maker and retail brand. He spoke at … Continue reading “Life Is Good, Listen to People, and More Takeaways from Bert Jacobs at MassChallenge”
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity
When Boston-based Rhythm Pharmaceuticals started up in 2010 with a plan to develop drugs to address diabetes and obesity, the biotech world was littered with companies struggling to make a mark in those disease areas. San Diego based Arena Pharmaceuticals was fighting to produce data for the FDA showing its obesity drug was safe. Phenomix, … Continue reading “MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity”
Kgbdeals and Mobile Spinach Hunt for Opportunities in Troubled Daily Deals Market
In spite of companies crumbling in the daily deals space, New York’s kgbdeals and San Mateo, CA’s Mobile Spinach believe they can survive in this now-brutal sector. Kgbdeals, part of directory assistance company kgb, acquired New York’s TheDealist last Wednesday to expand its reach with customers. Before kgbdeals could uncork the champagne, a rival deals … Continue reading “Kgbdeals and Mobile Spinach Hunt for Opportunities in Troubled Daily Deals Market”
SiOnyx, Black Silicon Startup of the North Shore, Shows Its Solar Cell Tech Is For Real
In a very difficult climate for U.S. solar companies, one Boston-area startup has made some significant progress in solar technology. SiOnyx, a Beverly, MA-based semiconductor company known for its “black silicon” approach to various applications, including solar cells, is reporting today that it has achieved an overall efficiency that is higher than the current industry … Continue reading “SiOnyx, Black Silicon Startup of the North Shore, Shows Its Solar Cell Tech Is For Real”
MassChallenge Awards $100K to Alkeus, Sanergy, and Tinfoil; 14 Others Get $50K in Accelerator Program’s Second Year
Another year, another MassChallenge class. The sophomore edition of the startup accelerator and $1 million business plan competition did not disappoint. Nor did the final event of the program. Tonight was the big awards gala, held at the Boston Convention & Exhibition Center in South Boston—a cavernous and sprawling, impersonal space—but it did the job. … Continue reading “MassChallenge Awards $100K to Alkeus, Sanergy, and Tinfoil; 14 Others Get $50K in Accelerator Program’s Second Year”
They’re Under 30. They Probably Can.
It’s getting tiring to hear that the United States can’t. Can’t innovate anymore. Can’t create jobs. But if you look around Massachusetts I think you’ll come to the conclusion that if anyone can, it’s probably people under 30 (plus or minus). I’m sitting in an old mill building in Holyoke. There are almost 100,000 students … Continue reading “They’re Under 30. They Probably Can.”
MIT Enterprise Forum: Defeating Alzheimer’s
Info and registration details here. Alzheimer’s Disease devastates the lives of 25-40 million people worldwide — a number that is projected to quadruple in the coming decades. There are currently no FDA-approved medicines that can significantly modify the course of the disease. There is no effective means for early detection and diagnosis. Furthermore, neurodegeneration is … Continue reading “MIT Enterprise Forum: Defeating Alzheimer’s”
MIT Enterprise Forum: Changing the World: How Innovators Are Using the Web for Social Action
Information and registration details here. Using business methods and entrepreneurial skills to solve the world’s most dire social ills is attracting all kinds of attention. Social entrepreneurship and the blending of for-profit with non-profit models are just two recent trends hoping to make the world a better place. And tech innovations — from mobile devices … Continue reading “MIT Enterprise Forum: Changing the World: How Innovators Are Using the Web for Social Action”
VC Investment in MA Companies Falls Back to Earth (from $1B to $505M): Top 10 Q3 Deals
Here comes another venture capital downturn. Maybe. That’s my not-so-definitive take after looking at the VC investment numbers for Massachusetts in the third quarter of 2011, which broadly reflected the national trend as well. How any such downturn will compare to 2008-09 is anyone’s guess. Maybe it’s just a blip, or a healthy resetting after … Continue reading “VC Investment in MA Companies Falls Back to Earth (from $1B to $505M): Top 10 Q3 Deals”
Sanofi Names David Meeker New CEO of Genzyme, Will Report to Viehbacher
Genzyme only had one leader for more than 25 years, and it has found a new one in David Meeker, now that the company is part of Paris-based pharmaceutical giant Sanofi. Meeker will become the CEO of the Cambridge, MA-based Genzyme unit starting Nov. 1, and will report to Sanofi CEO Chris Viehbacher, according to … Continue reading “Sanofi Names David Meeker New CEO of Genzyme, Will Report to Viehbacher”
Pintley, a MassChallenge Finalist, Looks to Turn Beer Industry On Its Head With Social Apps
I don’t like playing favorites. I just really like beer. Especially after this weekend. But enough about me. A couple of weeks ago, I got to chat with Tim Noetzel, the co-founder of Pintley, a Boston-based beer website that provides personalized recommendations, tasting notes, and a social community. Pintley is a participant in this year’s … Continue reading “Pintley, a MassChallenge Finalist, Looks to Turn Beer Industry On Its Head With Social Apps”
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better
We’ve heard warnings for a couple of years now that the chickens would come home to roost in the biotech venture capital scene. Quite a few VCs just haven’t delivered the returns to back up all their talk, and you can’t wait around forever for things to improve. This drama is going to be long … Continue reading “Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better”
PharmaSecure Lands $3,900,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1f93be73-4111-49fa-bff0-add8ea2edf28&Preview=1 Date 10/24/2011 Company Name PharmaSecure Mailing Address 16 Cavendish Court Lebanon, NH 03766 Company Description At PharmaSecure, our mission is twofold: to end the public health menace of pharmaceutical counterfeiting, and to help manufacturers communicate more effectively with their customers. Our systems cut out counterfeiters by creating a simple, secure, and … Continue reading “PharmaSecure Lands $3,900,000 New Financing Round”
Babson Entrepreneurship Forum
Info and registration here. In honor of its 10th anniversary, this year’s Forum is an exclusive three-day event, running from November 11-13th. During these three days, attendees will be given the opportunity to participate in professionally led workshops, networking opportunities, business plan competitions and more! he Forum is Babson’s largest student-run event.
DartBoston’s MassTLC unConference Pre-Party
Info and registration here. DartBoston and MassTLC have joined forces to bring you the best unConference pre-party in history! Special thanks to Terrible Labs for sponsoring the event!
Sha Mi, Biogen Idec’s Neurology Ace, to Join “The Genetics Institute Impact” on Dec. 14
One of the scientists at Biogen Idec pushing for a new kind of regenerative medicine got some of her most valuable experience, and inspiration, back in the day at Genetics Institute. So we’re thrilled to have Sha Mi join what is shaping up to be a truly special gathering of alumni from GI, one of … Continue reading “Sha Mi, Biogen Idec’s Neurology Ace, to Join “The Genetics Institute Impact” on Dec. 14″
This Week’s Xconomy Report on WGBH: Security Innovation, Vertex, West Coast Acquisitions, & More
Our exciting partnership with the folks at WGBH continues. Check out this morning’s Xconomy report—a roundup of business, technology, and life sciences news that airs every Friday at 7:49am on 89.7 FM. Today’s news: Wilmington, MA-based Security Innovation is involved in a transportation safety project that will test a wireless collision avoidance system for cars. … Continue reading “This Week’s Xconomy Report on WGBH: Security Innovation, Vertex, West Coast Acquisitions, & More”
From the Lab that Brought You Siri, It’s Trapit—A Personalized Discovery Engine
There are two kinds of people: Those who already own an iPhone 4S, and those who don’t but have seen Apple’s Siri ads and wish they did. Siri, of course, is the voice-operated personal assistant that can read your text messages, schedule appointments, check on the weather, make waffles, and babysit your toddler (just kidding … Continue reading “From the Lab that Brought You Siri, It’s Trapit—A Personalized Discovery Engine”
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News
This week New England’s life sciences community saw a couple of cool new companies emerge and a few potentially important new treatments reach key milestones. —Boston-based Third Rock Ventures launched its newest startup with $35 million to develop a new class of drugs for brain disorders such as schizophrenia and depression. Sage Therapeutics’ approach is … Continue reading “Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News”
Hadapt Nabs $8M VC Round, Will Move from New Haven to Boston to Cash In on Big Data
[Updated 12:20pm. See below] A buzz-worthy New England tech startup is relocating from Connecticut to the Boston area after raising a sizable venture capital round, Xconomy has learned. New Haven, CT-based Hadapt has closed a Series A financing round, according to two sources with knowledge of the company. One source puts the round at $8 … Continue reading “Hadapt Nabs $8M VC Round, Will Move from New Haven to Boston to Cash In on Big Data”
MedVentive Lands $12,900,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f4e44a37-9a5a-49d4-abac-7bf2dd507b18&Preview=1 Date 10/21/2011 Company Name MedVentive Mailing Address 400 Fifth Avenue Waltham, MA 02451 Company Description MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Website … Continue reading “MedVentive Lands $12,900,000 New Financing”
Hadapt Receives $8,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f720169c-794a-46a0-b081-b5fdec464752&Preview=1 Date 10/21/2011 Company Name Hadapt Mailing Address Undisclosed New Haven , CT 06510 Company Description Hadapt offers an adaptive analytical platform for performing complex analytics on structured and unstructured data, all in one cloud-optimized system. Website http://www.hadapt.com Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction Round Undisclosed Proceeds Purposes proceeds purposes … Continue reading “Hadapt Receives $8,000,000 New Funding Round”
OPKO Health Acquires Claros Diagnostics for $49,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0881fc34-4788-4605-ab35-f60bd60a615c&Preview=1 Date 10/21/2011 Company Name Claros Diagnostics Mailing Address 4 Constitution Way Woburn, MA 01801 Company Description Claros has developed a novel handheld immunoassay system incorporating a lab-on-a-chip configuration which produces high performance quantitative laboratory blood test results with the ease-of-use of rapid qualitative diagnostic test strips. The Claros device will enable … Continue reading “OPKO Health Acquires Claros Diagnostics for $49,000,000”
Venture Industry Calls for Rules Changes to Reopen IPO Market
There was a time when most growing companies went to the public stock markets for the capital they needed to keep hiring and growing—but that time ended a decade ago. At no point since 2001 has the number of initial public offerings per year reached even the minimum levels set in the 1990s. (The pre-1999 … Continue reading “Venture Industry Calls for Rules Changes to Reopen IPO Market”